EVOGENE LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 255.1 ILa | -1.58% |
|
+8.65% | -14.91% |
| Apr. 02 | Evogene Ltd. and The Kitchen FoodTech Hub Establishes Finally Foods Ltd | CI |
| Mar. 20 | Evogene Receives Minimum Bid Price Non-Compliance Notice From Nasdaq | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 39.24 | 170.9 | 71.25 | 26.24 | 41.96 | 33.94 | - | - |
| Enterprise Value (EV) 1 | 39.24 | 170.9 | 71.25 | 26.24 | 41.96 | 33.94 | 33.94 | 33.94 |
| P/E ratio | -7.51 x | - | - | - | - | - | - | - |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | - | 164 x | 76.6 x | 15.7 x | 7.44 x | 2 x | 1.08 x | 0.57 x |
| EV / Revenue | - | 164 x | 76.6 x | 15.7 x | 7.44 x | 2 x | 1.08 x | 0.57 x |
| EV / EBITDA | - | - | - | - | -1.91 x | -1.91 x | -2.53 x | -170 x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Price to Book | - | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 25,754 | 35,575 | 41,164 | 41,216 | 50,550 | 50,623 | - | - |
| Reference price 2 | 5.256 | 15.44 | 5.375 | 2.235 | 2.998 | 2.551 | 2.551 | 2.551 |
| Announcement Date | 3/4/20 | 3/3/21 | 3/10/22 | 3/9/23 | 3/7/24 | - | - | - |
1ILS in Million2
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 1.04 | 0.93 | 1.675 | 5.64 | 17 | 31.5 | 60 |
| EBITDA 1 | - | - | - | - | -22.02 | -17.72 | -13.42 | -0.2 |
| EBIT 1 | - | -24.81 | -30.95 | -26.94 | -26.51 | -22.92 | -19.22 | -7.4 |
| Operating Margin | - | -2,385.96% | -3,328.28% | -1,608.42% | -470% | -134.85% | -61.03% | -12.33% |
| Earnings before Tax (EBT) 1 | - | -26.17 | -30.43 | -29.75 | -25.99 | -22.92 | -19.22 | -7.4 |
| Net income 1 | -18.11 | -23.37 | -27.79 | -26.64 | -23.88 | -20.92 | -17.22 | -5.4 |
| Net margin | - | -2,247.5% | -2,988.49% | -1,590.33% | -423.39% | -123.09% | -54.68% | -9% |
| EPS | -0.7000 | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 3/4/20 | 3/3/21 | 3/10/22 | 3/9/23 | 3/7/24 | - | - | - |
1USD in Million
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 0.151 | 0.311 | 0.237 | 0.312 | 0.466 | 0.66 | 0.641 | 0.654 | 3.767 | 0.578 | 3.5 | 2.5 | 8 | 3 | 2.5 |
| EBITDA 1 | - | - | - | - | - | - | -5.737 | -6.453 | -2.977 | -6.852 | -3.55 | -5.325 | -3.5 | -5.35 | - |
| EBIT 1 | -8.556 | -8.692 | -8.055 | -8.007 | -7.097 | -3.782 | -6.796 | -7.901 | -4.183 | -7.628 | -4.85 | -6.625 | -4.8 | -6.65 | - |
| Operating Margin | -5,666.23% | -2,794.86% | -3,398.73% | -2,566.35% | -1,522.96% | -573.03% | -1,060.22% | -1,208.1% | -111.04% | -1,319.72% | -138.57% | -265% | -60% | -221.67% | - |
| Earnings before Tax (EBT) 1 | -8.335 | -8.09 | -9.104 | -9.716 | -7.158 | -3.776 | -7.026 | -7.757 | -3.863 | -7.341 | -4.85 | -6.625 | -4.8 | -6.65 | - |
| Net income 1 | -7.61 | -7.371 | -9.106 | -8.821 | -6.544 | -2.998 | -6.271 | -7.023 | -3.984 | -6.601 | -4.35 | -6.125 | -4.3 | -6.15 | - |
| Net margin | -5,039.74% | -2,370.1% | -3,842.19% | -2,827.24% | -1,404.29% | -454.24% | -978.32% | -1,073.85% | -105.76% | -1,142.04% | -124.29% | -245% | -53.75% | -205% | - |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/17/21 | 3/10/22 | 5/26/22 | 8/31/22 | 11/17/22 | 3/9/23 | 5/18/23 | 8/17/23 | 11/15/23 | 3/7/24 | - | - | - | - | - |
1USD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex | - | - | - | 1.17 | - | - | - | - |
| Capex / Sales | - | - | - | 69.91% | - | - | - | - |
| Announcement Date | 3/4/20 | 3/3/21 | 3/10/22 | 3/9/23 | 3/7/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -14.91% | 33.86M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- EVGN Stock
- Financials Evogene Ltd.
